wavelight^® EX500 Excimer Laser

Wavelight^® EX500 Excimer Laser

Combines state-of-the-art refractive technology to produce fast, effective, and reliable procedures^1-5

Exceptional refractive outcomes: provides excellent reproducible and predictable outcomes⁶

Robust and proven technology: trusted market leader in excimer technology^7,8

Guiding technology: operate with confidence⁹

Versatile LASIK procedure: treat a wide range of patients⁹

The trusted leader in excimer technology worldwide^7,8

wavelight^® excimer technology has been used by surgeons globally for more than 20 years⁷

FDA-approved technology with 6 completed IDE studies

wavelight^® technology has been the subject of more than 100 clinical studies¹⁰

wavelight^® EX500 is the #1 most installed excimer laser worldwide⁸*

wavelight^® EX500 is used by more than 6000 surgeons worldwide^†

Surgeons in more than 80 countries^‡ count on wavelight^® EX500 to provides their patients with exceptional outcomes¹¹

*Data current as of 2022.

^†Alcon sales data; calculated based on an average of 3 surgeons operating per account (total install base = 2004 units).

^‡Alcon wavelight^® EX500 install base data from Service Max, March 2023.

Deliver a wide range of treatment options for every eligible patient profile

wavelight^® EX500 provides a range of refractive treatment types tailored to your patient’s individual needs and vision goals.⁹

Table of treatment types tailored to your patient’s individual needs and vision goals

Deliver the vision patients demand with proven clinical outcomes

Achieve exceptional post-operative outcomes with wavelight^® EX500

Table of post-operative results for wavelight® EX500

UNVA: uncorrected near visual acuity

UDVA: uncorrected distance visual acuity

CDVA: corrected distance visual acuity

*n=180 eyes

^†n=50 eyes

^‡n=130 eyes

^§n=500 eyes

^‖n=98 eyes

^¶3 months post-op; n=212 eyes

Please refer to relevant product’s Instructions for Use for complete list of indications, contraindications and warnings.

Discover the wavelight portfolio

Your equipment deserves patient level care

Through our unrivaled commitment to service excellence, at Alcon Services, we partner with you to give you peace of mind, knowing your practice will continue to deliver optimal patient outcomes and performance.

Clinical Support

Gonzalez-Cruces T, et al. Comparison between the wavefront-optimized and custom-Q aspheric ablation profiles in myopic eyes with two different Q-targets: A contralateral eye study

Comparing two aspheric ablation profiles in myopic refractive surgery using different asphericity targets.

Abdelwahab SM, Salem MH & Elfayoumi MA. Single-step transepithelial photorefractive keratectomy in low to moderate myopia: A one-year follow-up study.

Evaluating the predictability, safety, efficacy, and visual outcomes of the single-step transepithelial photorefractive keratectomy platform: wavelight™.

Kanellopoulos AJ. Topography-guided LASIK versus small incision lenticule extraction (SMILE) for myopia and myopic astigmatism: A randomized, prospective contralateral eye study.

A comparative study on the safety and efficacy of topography-guided LASIK and contralateral eye SMILE for myopia and myopic astigmatism correction.

Stulting RD, & Fant BS. Results of topography-guided laser in situ keratomileusis custom ablation treatment with a refractive excimer laser.

Evaluating the safety and effectiveness of topography-guided custom ablation treatment (T-CAT) to correct myopia and myopic astigmatism with laser in situ keratomileusis (LASIK).